Stock Analysis | Fastenal Outlook - Mixed Signals Emerge as Analysts Stay Bullish, Technicals Signal Caution
Market Snapshot
Fastenal (FAST) has seen a recent price rise of 8.08%, with a Buy rating from Baird analyst David Manthey. However, our internal diagnostic score (0-10) for technical strength stands at 3.23, suggesting caution due to bearish indicators. The fundamentals, meanwhile, score 4.95, showing moderate resilience.
News Highlights
Recent headlines offer a mix of unrelated global and sector-specific news:
- May 28, 2025: Cboe Global MarketsCBOE-- announced the departure of its Global President, introducing uncertainty into the broader market environment. While not directly tied to FastenalFAST--, this adds to the backdrop of market volatility.
- May 30, 2025: Cooper CompaniesCOO-- reported a 6% year-over-year revenue increase, raising its FY25 EPS guidance. This signals strength in industrial and medical sectors, potentially benefiting Fastenal's distribution business.
- May 31, 2025: BitcoinBTC-- advocate Max Keiser questioned the sustainability of new BTC treasury companies, highlighting broader crypto market concerns. Fastenal is not directly impacted, but broader investor sentiment may be affected.
Analyst Views & Fundamentals
Fastenal has received a recent Buy rating from Baird, with a historical win rate of 100%. The simple average analyst rating is 4.00, while the performance-weighted score is 6.44, suggesting strong alignment with positive price action. The stock is currently up 8.08%, matching the weighted optimism among analysts.
Key Fundamental Factors
- Price-to-Cash Flow (PCF): 43.57 (Score: 1 internal diagnostic score (0-10))
- ROE (Return on Equity): 8.68% (Score: 3 internal diagnostic score (0-10))
- Net Income / Revenue: 43.73% (Score: 3 internal diagnostic score (0-10))
- Cash-UP: 4.26 (Score: 2 internal diagnostic score (0-10))
- EBIT / Operating Revenue: 20.55% (Score: 3 internal diagnostic score (0-10))
- Shareholders' Equity Growth Rate (Y/Y): 5.28% (Score: 1 internal diagnostic score (0-10))
- Current Liabilities / Total Liabilities: 67.86% (Score: 0 internal diagnostic score (0-10))
Money-Flow Trends
Fastenal is experiencing a negative overall trend in fund flows, with most investor categories showing outflows:
- Small investors: 49.49% inflow ratio with a negative trend
- Medium investors: 49.17% inflow ratio with a negative trend
- Large investors: 48.49% inflow ratio with a negative trend
- Extra-large investors: 38.88% inflow ratio with a negative trend
- Block flows: 40.99% inflow ratio, also showing a negative trend
The internal diagnostic score (0-10) for fund flows is 6.76, indicating a good flow profile despite the negative directional bias.
Key Technical Signals
Fastenal’s technical outlook is mixed to bearish with the following internal diagnostic scores (0-10):
- RSI Overbought: 3.65 (internal diagnostic score (0-10))
- WR Overbought: 1.91 (internal diagnostic score (0-10))
- MACD Golden Cross: 4.13 (internal diagnostic score (0-10))
Recent indicator activity (last 5 days):
- August 11: WR Overbought
- August 13: WR Overbought + RSI Overbought
- August 12: WR Overbought + MACD Golden Cross
- August 15: WR Overbought
- August 14: WR Overbought
Key technical insights show 2 bearish indicators and 0 bullish indicators, with the WR Overbought and RSI Overbought signaling caution. The overall trend is weak, and the model advises to avoid entry at current levels.
Conclusion
Fastenal is in a mixed condition with strong fundamental readings (4.95 internal diagnostic score (0-10)) and a high fund-flow score (6.76 internal diagnostic score (0-10)). However, the technical indicators remain bearish (3.23 internal diagnostic score (0-10)), with overbought signals and weak momentum.
Actionable Takeaway: Consider waiting for a pull-back before entering a position. Monitor the RSI and WR levels for a potential reversal signal. Investors should also watch for follow-up analyst commentary from Baird and broader market volatility trends.
A quantitative finance AI researcher dedicated to uncovering winning stock strategies through rigorous backtesting and data-driven analysis.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments
No comments yet